184 related articles for article (PubMed ID: 34196706)
1. High linear energy transfer carbon-ion irradiation upregulates PD-L1 expression more significantly than X-rays in human osteosarcoma U2OS cells.
Permata TBM; Sato H; Gu W; Kakoti S; Uchihara Y; Yoshimatsu Y; Sato I; Kato R; Yamauchi M; Suzuki K; Oike T; Tsushima Y; Gondhowiardjo S; Ohno T; Yasuhara T; Shibata A
J Radiat Res; 2021 Sep; 62(5):773-781. PubMed ID: 34196706
[TBL] [Abstract][Full Text] [Related]
2. VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation.
Fujisawa H; Nakajima NI; Sunada S; Lee Y; Hirakawa H; Yajima H; Fujimori A; Uesaka M; Okayasu R
Radiat Oncol; 2015 Aug; 10():175. PubMed ID: 26286029
[TBL] [Abstract][Full Text] [Related]
3. Role of BCLAF-1 in PD-L1 stabilization in response to ionizing irradiation.
Ma Z; Wang H; Meng F; Han Y; Chen Y; Xiao M; Jiang H; Yu Z; Xu B
Cancer Sci; 2021 Oct; 112(10):4064-4074. PubMed ID: 34251713
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells.
Song N; Bai M; Che X; Li Z; Jing W; Li C; Teng Z; Qu X; Liu Y
Med Oncol; 2020 Apr; 37(5):47. PubMed ID: 32277292
[TBL] [Abstract][Full Text] [Related]
5. KPNB1 Inhibitor Importazole Reduces Ionizing Radiation-Increased Cell Surface PD-L1 Expression by Modulating Expression and Nuclear Import of IRF1.
Yoshino H; Sato Y; Nakano M
Curr Issues Mol Biol; 2021 May; 43(1):153-162. PubMed ID: 34069326
[TBL] [Abstract][Full Text] [Related]
6. Analysis of programmed death-ligand 1 expression in primary normal human dermal fibroblasts after DNA damage.
Hagiwara Y; Sato H; Permata TBM; Niimi A; Yamauchi M; Oike T; Nakano T; Shibata A
Hum Immunol; 2018 Aug; 79(8):627-631. PubMed ID: 29859207
[TBL] [Abstract][Full Text] [Related]
7. IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling.
Padmanabhan S; Gaire B; Zou Y; Uddin MM; Vancurova I
Cell Signal; 2022 Sep; 97():110400. PubMed ID: 35820543
[TBL] [Abstract][Full Text] [Related]
8. Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.
Saha J; Wang M; Cucinotta FA
DNA Repair (Amst); 2013 Dec; 12(12):1143-51. PubMed ID: 24238855
[TBL] [Abstract][Full Text] [Related]
9. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
Iijima M; Okonogi N; Nakajima NI; Morokoshi Y; Kanda H; Yamada T; Kobayashi Y; Banno K; Wakatsuki M; Yamada S; Kamada T; Aoki D; Hasegawa S
J Gynecol Oncol; 2020 Mar; 31(2):e19. PubMed ID: 31912675
[TBL] [Abstract][Full Text] [Related]
10. Heavy ion beams induce survivin expression in human hepatoma SMMC-7721 cells more effectively than X-rays.
Gong L; Jin X; Li Q; Liu J; An L
Acta Biochim Biophys Sin (Shanghai); 2007 Aug; 39(8):575-82. PubMed ID: 17687492
[TBL] [Abstract][Full Text] [Related]
11. ATR signaling cooperates with ATM in the mechanism of low dose hypersensitivity induced by carbon ion beam.
Xue L; Furusawa Y; Yu D
DNA Repair (Amst); 2015 Oct; 34():1-8. PubMed ID: 26246317
[TBL] [Abstract][Full Text] [Related]
12. Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression.
Garcia-Diaz A; Shin DS; Moreno BH; Saco J; Escuin-Ordinas H; Rodriguez GA; Zaretsky JM; Sun L; Hugo W; Wang X; Parisi G; Saus CP; Torrejon DY; Graeber TG; Comin-Anduix B; Hu-Lieskovan S; Damoiseaux R; Lo RS; Ribas A
Cell Rep; 2017 May; 19(6):1189-1201. PubMed ID: 28494868
[TBL] [Abstract][Full Text] [Related]
13. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
He J; Zhang W; Di T; Meng J; Qi Y; Li G; Zhang Y; Su H; Yan W
Biomed Pharmacother; 2020 Nov; 131():110541. PubMed ID: 33152901
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 expression is low in large B-cell lymphoma with MYC or double-hit translocation.
Elbaek MV; Pedersen MØ; Breinholt MF; Reddy A; Love C; Clasen-Linde E; Knudsen H; Nielsen SL; Gang AO; Høgdall E; Dave S; Nørgaard P
Hematol Oncol; 2019 Oct; 37(4):375-382. PubMed ID: 31408531
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-1 induced programmed death-ligand 1-mediated immunosuppression by activating the STAT3 pathway in osteosarcoma.
Liu Z; Wen J; Hu F; Wang J; Hu C; Zhang W
Cancer Sci; 2022 Feb; 113(2):432-445. PubMed ID: 34927311
[TBL] [Abstract][Full Text] [Related]
16. WEE1 inhibitor and ataxia telangiectasia and RAD3-related inhibitor trigger stimulator of interferon gene-dependent immune response and enhance tumor treatment efficacy through programmed death-ligand 1 blockade.
Wu X; Kang X; Zhang X; Xie W; Su Y; Liu X; Guo L; Guo E; Li F; Hu D; Qin X; Fu Y; Peng W; Jia J; Wang C
Cancer Sci; 2021 Nov; 112(11):4444-4456. PubMed ID: 34382294
[TBL] [Abstract][Full Text] [Related]
17. RNF8 promotes high linear energy transfer carbon-ion-induced DNA double-stranded break repair in serum-starved human cells.
Nakajima NI; Yamauchi M; Kakoti S; Cuihua L; Kato R; Permata TBM; Iijima M; Yajima H; Yasuhara T; Yamada S; Hasegawa S; Shibata A
DNA Repair (Amst); 2020; 91-92():102872. PubMed ID: 32502756
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma.
Liu Z; Wen J; Wu C; Hu C; Wang J; Bao Q; Wang H; Wang J; Zhou Q; Wei L; Shen Y; Zhang W
Aging (Albany NY); 2020 Jan; 12(2):1213-1236. PubMed ID: 31981455
[TBL] [Abstract][Full Text] [Related]
19. DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells.
Sato H; Niimi A; Yasuhara T; Permata TBM; Hagiwara Y; Isono M; Nuryadi E; Sekine R; Oike T; Kakoti S; Yoshimoto Y; Held KD; Suzuki Y; Kono K; Miyagawa K; Nakano T; Shibata A
Nat Commun; 2017 Nov; 8(1):1751. PubMed ID: 29170499
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas.
Spurny C; Kailayangiri S; Jamitzky S; Altvater B; Wardelmann E; Dirksen U; Hardes J; Hartmann W; Rossig C
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28868758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
